People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Curis Inc | — | Biotechnology | Pre-Seed | $964K | $53.2M | 2012 |
Susan B. Bayh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Susan B. Bayh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James R. Tobin | 1 | 6 |
| James R. McNab, Jr. | 1 | 3 |
| Martyn D. Greenacre | 1 | 3 |
| Robert E. Martell | 1 | 2 |
| Daniel R. Passeri | 1 | 2 |
| Kenneth I. Kaitin | 1 | 2 |
| Marc R. Rubin | 1 | 1 |
| Maurizio W. Voi | 1 | 1 |
| Mark W. Noel | 1 | 1 |
| Michael P. Gray | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.